Cyanotech News


	: Contact	: Search

8/15/09	Cyanotech Reports Financial Results for the First Quarter of Fiscal 2009
7/16/08	Cyanotech Corporation Announces Selection of Grant Thornton LLP as Independent Registered Public Accountants
6/26/08	Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2008
5/19/08	Cyanotech Names Andrew Jacobson as President & CEO
3/26/08	Cyanotech Focuses Natural Astaxanthin Production on BioAstin® for Human Market, Discontinues Production of NatuRose® for Animal Feed Market in Strategic Move
2/14/08	Cyanotech Reports Financial Results for the Third Quarter of Fiscal 2008
1/31/08	Cyanotech Provides Marketing Update
11/13/07	Cyanotech Announces Strategic Shift to Marketing-Oriented Business Model, Initiates Search for New President and CEO to Lead Effort
11/7/07	Cyanotech Reports Improved Financial Results for the Second Quarter of Fiscal 2008
10/15/07	Cyanotech Reports GMP Certification, Launches Two New Products
10/8/07	Cyanotech Receives Notice of Compliance from Nasdaq
9/21/07	Cyanotech Reports First Quarter Fiscal 2008 Financial Results
8/16/07	Cyanotech Files Form 10-K Financial Report for Fiscal 2007
6/5/07	Cyanotech Issues Statement on Product Integrity
4/4/07	Cyanotech Corp. Appoints Natural Products Industry Veteran Marc G. Ketchel to Serve as Director of Sales
3/16/07	Cyanotech Receives Notice of Compliance from Nasdaq
3/5/07	Cyanotech’s BioAstin® Natural Astaxanthin Is Officially Registered in the European Union
2/26/07	Cyanotech Files Form 10-Q Financial Reports for First Quarter and Second Quarter of Fiscal Year 2007; Delays Third Quarter Fiscal 2007 Form 10-Q Financial Report; Nasdaq Notice of Non-Compliance With Listing Requirement, and Cyanotech Request for Continued Nasdaq Listing
2/14/07	Cyanotech Files Fiscal Year 2006 Form 10-K/A Restating Its Financial Results; Seeks Delay of Third Quarter Fiscal 2007 Form 10-Q Financial Report
12/20/06	Cyanotech Receives Extension from Nasdaq to File Its Late Reports and Restatements
11/14/06	Cyanotech Corporation Delays Filing
11/3/06	Cyanotech Corporation Announces Reverse Split of Its Par Value $0.005 Common Stockand Temporary 30-day Change in Its Symbol from CYAN to CYAND
10/16/06	Cyanotech Reports No Significant Damage from Earthquake
9/21/06	Cyanotech Board Approves 1-for-4 Reverse Stock Split and Other News
8/24/06	Cyanotech Receives Delisting Notice from NASDAQ Due to Late Filing of Form 10-Q
8/21/06	Cyanotech Continues Delay of First Quarter Fiscal 2007 Financial Results
8/16/06	Cyanotech 1Q07 Extension Filing
8/9/06	Cyanotech Delays First Quarter Fiscal 2007 Financial Results
5/31/06	Nasdaq Extends Cyanotech Listing Compliance Period to November 27, 2006
5/24/06	Cyanotech Reports 4QFY06 Results: Fiscal Year Sales Down 3%; 4Q Sales Up 27%
3/23/06	Study Indicates Significant Increase in Grip Strength Measurements in Subjects with Tennis Elbow (Tendonitis) When Using Cyanotech’s BioAstin® Natural Astaxanthin
3/13/06	Earthrise and Cyanotech Claim Significant Differences between Organic and All-natural, American-made Spirulina
3/2/06	Study of Cyanotech’s BioAstin® Natural Astaxanthin Indicates Significant Reduction in Systemic Inflammation in Humans
2/13/06	Astaxanthin softens sales blow for Cyanotech
2/8/06	Cyanotech Reports Third-Quarter Fiscal 2006 Financial Results
2/1/06	Hawaiian microalgae producer Cyanotech has become the latest company to tout its wares direct to consumers, with the initiation of an advertising campaign aimed at end users of BioAstin.
2/1/06	Cyanotech Corporation Announces FY 2006 Third Quarter Financial Results Webcast on February 8, 2006
1/31/06	Cyanotech Retains Media Relations for Consumer PR Campaign
1/11/06	Cyanotech counts on China for astaxanthin expansion
12/13/05	Cyanotech Names William R. Maris as CFO
12/06/05	Cyanotech Receives Non-Compliance Notice from Nasdaq — Company has 180 days to comply
11/30/05	Cyanotech CEO Reports on Business Development Trip to Asia
11/03/05	Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results (Reports Sales of $2,517,000, Net Loss of $321,000)
10/28/05	Cyanotech Corporation Announces FY 2006 Second Quarter Financial Results Webcast on November 3, 2005
10/15/05	Cyanotech Corporation Announces Resignation of Jeffrey H. Sakamoto, Chief Financial Officer
08/31/05	Dutton Associates Announces Investment Opinion: Cyanotech Neutral Rating Based on Valuation Maintained by Dutton Associates
08/11/05	Cyanotech Corporation Reports First Quarter Fiscal 2006 Financial Results; Reports Net Income of $153,000 on Sales of $3,029,000
07/15/05	Dutton Associates Announces Investment Opinion: Cyanotech Neutral Rating Maintained By Dutton Associates
07/12/05	Cyanotech Appoints Russell Communications Group as Investor Relations and Marketing Communications Agency
06/08/05	Cyanotech Corporation Announces Results of Independent Laboratory Testing of Spirulina
05/16/05	Cyanotech Corporation Reports Fourth Quarter and Fiscal Year-End 2005 Financial Results; Company Reports Net Income of $486,000 for the Fiscal Year Ended March 31, 2005
12/06/04	Dr. Gerald Cysewski, Chairman, President and CEO of Cyanotech Talks to The Wall Street Transcript
11/11/03	United States-Grown Spirulina Completes FDA Generally Recognized As Safe(GRAS) Notification Process
10/15/02	Popping Pills to Prevent Sunburns? Diet supplement claims to stop sun damage, but some say that's hard to swallow.
10/07/02	Cyantech Reports Two Clinical Studies of BioAstin® Are Presented at American College of Nutrition Meeting
06/06/02	Cyanotech Receives Notice of Alllowance for Patent Covering the Use of Astaxanthin to Retard and Prevent Sunburn
05/22/02	Cyanotech Reports Positive Clinical Results from Use of BioAstin® for Rheumatoid Arthritis
05/07/02	Cyanotech Reports Positive Clinical Results from Use of BioAstin® for Carpal Tunnel Syndrome
04/17/02	Human Research Indicates Supportive Role for Spirulina in Fighting Cancer
10/11/01	Cyanotech Receives Notice of Allowance for Canker Sore Patent
05/20/01	A Pill to Banish Deadly Sunburn—Drug could spell end of tan creams—Sunday Express
05/09/01	Cyanotech Announces Positive Results for BioAstin® as Sunburn Protection
05/01/01	Cyanotech Receives Notice of Allowance for Carpal tunnel Syndrome Patent
02/14/01	Human Clinical Trial Shows Spirulina May Increase Natural Cancer Fighting Substances in the Body
08/22/00	Cyanotech Receives FDA Approval for Its NatuRose® Salmon Feed Ingredient
01/18/00	Discover the brand-new fountain-of-youth vitamin—From "Woman World" Magazine
08/12/99	Algae's Napa Valley—Feature in Los Angeles Times